Attached files
file | filename |
---|---|
EX-17.1 - EX-17.1 - AMERICAN HOMEPATIENT INC | g24552exv17w1.htm |
EX-17.2 - EX-17.2 - AMERICAN HOMEPATIENT INC | g24552exv17w2.htm |
EX-99.1 - EX-99.1 - AMERICAN HOMEPATIENT INC | g24552exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported)
September 2, 2010 (September 1, 2010)
September 2, 2010 (September 1, 2010)
AMERICAN HOMEPATIENT, INC.
(Exact name of registrant as specified in its charter)
Nevada | 0-19532 | 27-2457306 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(Employer Identification Number) |
5200 Maryland Way, Suite 400, Brentwood, TN 37027-5018
(Address of principal executive offices)
(Address of principal executive offices)
(615) 221-8884
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
þ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement
On September 2, 2010, American HomePatient, Inc. (the Company) entered into a First Lien
Credit Agreement and Second Lien Credit Agreement (collectively, the Credit Agreements), each
with General Electric Capital Corporation (GECC) as lender and agent, and certain other lenders,
including certain affiliates of Highland Capital Management, L.P. (Highland). Pursuant to the
terms of that certain Restructuring Support Agreement entered into April 27, 2010 between the
Company and its senior lenders (the Restructuring Support Agreement), Highland and the Companys
other senior lenders agreed to restructure the Companys outstanding senior debt, which had matured
in August of 2009, subject to a number of conditions, including, among others, the successful
completion of a self-tender offer. The Company, Highland, GECC and the Companys other senior
lenders entered into the Credit Agreements to effect the restructuring of the Companys senior debt
upon the successful closing of the self-tender offer as contemplated by the Restructuring Support
Agreement.
The Companys senior debt has been restructured into a first lien $95.5 million term loan (the
First Lien Loan) and a second lien $120.7 million term loan (the Second Lien Loan), each with a
maturity date of September 2, 2014, and each with variable interest as provided in the applicable
Credit Agreement. The First Lien Loan bears interest at a rate equal to (x) in the case of LIBOR
Rate Loans, LIBOR (subject to a 2.80% floor) plus 4.00% and (y) in the case of Base Rate Loans,
Base Rate (subject to a 3.80% floor) plus 3.00%. The Second Lien Loan bears interest at a rate
equal to (x) in the case of LIBOR Rate Loans, LIBOR plus 7.00%, and (y) in the case of Base Rate
Loans, Base Rate plus 6.00%. LIBOR and Base Rate are determined on customary bases. Under certain
circumstances, the Company may pay a portion of the interest on the Second Lien Loan in-kind.
Obligations of the Company under the Credit Agreements are guaranteed by substantially all of the
Companys existing and future direct and indirect United States subsidiaries, with certain
customary or agreed-upon exceptions. The guarantors have pledged certain of their assets as
security for their obligations. The Second Lien Loan ranks junior in priority to the First Lien
Loan, pursuant to the terms of a customary intercreditor agreement.
The Credit Agreements require the Company to comply with customary affirmative, negative and
financial covenants. The Credit Agreements require that the Company maintain a minimum interest
coverage ratio and a maximum total debt to adjusted EBITDA (earnings before interest, taxes,
depreciation and amortization) ratio, or leverage ratio. The Credit Agreements also limit the
amount of capital expenditures the Company can make for any fiscal year, pursuant to calculations
set forth in the Credit Agreements.
The Credit Agreements contain customary events of default, including but not limited to
nonpayment; material inaccuracy of representations and warranties; violations of covenants and
other provisions of the Credit Agreements; certain bankruptcies and liquidations; certain
cross-defaults to material indebtedness; certain material judgments; certain events related to
certain pledges of the assets of the Company and those of certain of its subsidiaries, as security
for the obligations under the Credit Agreements; and certain changes of ownership.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
(a) Henry T. Blackstock and William C. ONeil have each resigned their positions as directors
of the Companys Board of Directors effective September 1, 2010. These resignations were tendered
at the Companys request which was required pursuant to the terms of the Restructuring Support
Agreement, and such resignations were not the result of any disagreement between any such director
and the Company. A copy of the resignation letter of each of the foregoing is attached hereto as
Exhibit 17.1 and 17.2, respectively.
Mr. Blackstock and Mr. ONeil each served on the Companys Nominating and Corporate
Governance, Audit and Compensation Committees prior to their resignation.
Item 8.01. Other Events
The Companys self-tender offer (the Offer) expired at 5:00 P.M. New York City time,
Wednesday, September 1, 2010. The Company has been advised that, pursuant to the terms of the
Offer, 6,917,314 Shares were tendered and not withdrawn prior to the expiration of the Offer. The
Company has accepted for purchase all of the shares of the Companys common stock (the Shares)
validly tendered and not withdrawn prior to the expiration of the Offer at a purchase price of
$0.67 cents per Share. The aggregate consideration for the accepted Shares of approximately
$4,634,600.38 will be delivered promptly by Computershare, the depositary for the Offer, to the
tendering shareholders on a pro rata basis. After the purchase of the accepted Shares, 10,746,075
Shares remain outstanding. The full text of the Companys press release, dated September 2, 2010,
announcing the expiration and the results of the Offer is filed as Exhibit 99.1 hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Number Exhibit
17.1 | Resignation Letter of Henry T. Blackstock from the Board of Directors dated
September 1, 2010. |
|||
17.2 | Resignation Letter of William C. ONeil, Jr. from the Board of Directors dated
September 1, 2010. |
|||
99.1 | Press Release dated September 2, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AMERICAN HOMEPATIENT, INC. |
||||
By: | /s/ Stephen L. Clanton | |||
Name: | Stephen L. Clanton | |||
Title: | Executive Vice President and Chief Financial Officer |
|||
Date: September 2, 2010